"At South Texas Cardiovascular Consultants, we're proud to serve heart patients in San Antonio, Kerrville, Boerne, New Braunfels and Fredericksburg. We're dedicated to providing preventive care, diagnostics and treatment options to our patients with heart disease. In addition to offering cutting-edge clinical trials, procedures and devices, our highly skilled team of cardiologists consists of interventional and non-interventional cardiologists, clinical cardiac electrophysiologists and nurse practitioners."

During the past decade, South Texas Cardiovascular Consultants conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Texas Cardiovascular Consultants" #1 sponsor was "Abbott Medical Devices" with 15 trials, followed by "Amgen" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Texas Cardiovascular Consultants" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "South Texas Cardiovascular Consultants" are "Heart Failure" (5 trials), "Atrial Fibrillation" (4 trials), "Bradycardia" (4 trials), "Coronary Artery Disease" (3 trials) and "Cardiac Rhythm Disorder" (2 trials). Many other conditions were trialed in "South Texas Cardiovascular Consultants" in a lesser frequency.

Most popular intervention types in "South Texas Cardiovascular Consultants" are "Device" (16 trials), "Drug" (10 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "Accent MRI system (lead safety)" (1 trials), "Accent MRI system (with MRI scan)" (1 trials) and "Ad5FGF-4" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Texas Cardiovascular Consultants" are 27 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "South Texas Cardiovascular Consultants". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in South Texas Cardiovascular Consultants, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in South Texas Cardiovascular Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".